BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22445005)

  • 1. Phase II trial of radiosurgery to magnetic resonance spectroscopy-defined high-risk tumor volumes in patients with glioblastoma multiforme.
    Einstein DB; Wessels B; Bangert B; Fu P; Nelson AD; Cohen M; Sagar S; Lewin J; Sloan A; Zheng Y; Williams J; Colussi V; Vinkler R; Maciunas R
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):668-74. PubMed ID: 22445005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme.
    Nwokedi EC; DiBiase SJ; Jabbour S; Herman J; Amin P; Chin LS
    Neurosurgery; 2002 Jan; 50(1):41-6; discussion 46-7. PubMed ID: 11844233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study Protocol: Early Stereotactic Gamma Knife Radiosurgery to Residual Tumor After Surgery of Newly Diagnosed Glioblastoma (Gamma-GBM).
    Brehmer S; Grimm MA; Förster A; Seiz-Rosenhagen M; Welzel G; Stieler F; Wenz F; Groden C; Mai S; Hänggi D; Giordano FA
    Neurosurgery; 2019 May; 84(5):1133-1137. PubMed ID: 29688510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes and prognostic stratification of patients with recurrent glioblastoma treated with salvage stereotactic radiosurgery.
    Sharma M; Schroeder JL; Elson P; Meola A; Barnett GH; Vogelbaum MA; Suh JH; Chao ST; Mohammadi AM; Stevens GHJ; Murphy ES; Angelov L
    J Neurosurg; 2018 Oct; 131(2):489-499. PubMed ID: 30485180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront boost Gamma Knife "leading-edge" radiosurgery to FLAIR MRI-defined tumor migration pathways in 174 patients with glioblastoma multiforme: a 15-year assessment of a novel therapy.
    Duma CM; Kim BS; Chen PV; Plunkett ME; Mackintosh R; Mathews MS; Casserly RM; Mendez GA; Furman DJ; Smith G; Oh N; Caraway CA; Sanathara AR; Dillman RO; Riley AS; Weiland D; Stemler L; Cannell R; Abrams DA; Smith A; Owen CM; Eisenberg B; Brant-Zawadzki M
    J Neurosurg; 2016 Dec; 125(Suppl 1):40-49. PubMed ID: 27903197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective trial of gross-total resection with Gliadel wafers followed by early postoperative Gamma Knife radiosurgery and conformal fractionated radiotherapy as the initial treatment for patients with radiographically suspected, newly diagnosed glioblastoma multiforme.
    Smith KA; Ashby LS; Gonzalez LF; Brachman DG; Thomas T; Coons SW; Battaglia M; Scheck A
    J Neurosurg; 2008 Dec; 109 Suppl():106-17. PubMed ID: 19123896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage stereotactic radiosurgery for recurrent glioblastoma multiforme with prior radiation therapy.
    Holt DE; Bernard ME; Quan K; Clump DA; Engh JA; Burton SA; Heron DE
    J Cancer Res Ther; 2016; 12(4):1243-1248. PubMed ID: 28169234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023.
    Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy.
    Reulen HJ; Poepperl G; Goetz C; Gildehaus FJ; Schmidt M; Tatsch K; Pietsch T; Kraus T; Rachinger W
    J Neurosurg; 2015 Sep; 123(3):760-70. PubMed ID: 26140493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Chen AM; Chang S; Pouliot J; Sneed PK; Prados MD; Lamborn KR; Malec MK; McDermott MW; Berger MS; Larson DA
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):825-30. PubMed ID: 17512132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
    Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1351-8. PubMed ID: 11121633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Chan AA; Lau A; Pirzkall A; Chang SM; Verhey LJ; Larson D; McDermott MW; Dillon WP; Nelson SJ
    J Neurosurg; 2004 Sep; 101(3):467-75. PubMed ID: 15352605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic radiosurgery versus fractionated stereotactic radiotherapy boost for patients with glioblastoma multiforme.
    Cho KH; Hall WA; Lo SS; Dusenbery KE
    Technol Cancer Res Treat; 2004 Feb; 3(1):41-9. PubMed ID: 14750892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiographic and histopathologic observations after combined EGFR inhibition and hypofractionated stereotactic radiosurgery in patients with recurrent malignant gliomas.
    Schwer AL; Kavanagh BD; McCammon R; Gaspar LE; Kleinschmidt-De Masters BK; Stuhr K; Chen C
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1352-7. PubMed ID: 19013723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
    McDonald MW; Shu HK; Curran WJ; Crocker IR
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):130-6. PubMed ID: 20399036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma Knife radiosurgery after radiation therapy as an adjunctive treatment for glioblastoma.
    Pouratian N; Crowley RW; Sherman JH; Jagannathan J; Sheehan JP
    J Neurooncol; 2009 Sep; 94(3):409-18. PubMed ID: 19330482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.